ArticleReproduction & fertility2025
DTPA disrupts development of preantral ovarian follicles in vitro.
Article in Reproduction & fertility, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- TPEN-Advanced Metal Chelator: From Characterization to Biomedical Applications.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Abstract: Dietary zinc deficiency disrupts fertility in vivo by impairing oocyte and embryo development near ovulation. Acute treatment of newborn ovaries with a strong intracellular chelator (TPEN), which preferentially binds zinc, disrupts follicular development. However, the chronic effects of transition metal chelation on preantral follicle development are not known. In this study, the effect of the extracellular transition metal chelator, diethylenetriaminepentaacetic acid (DTPA), was used to examine more prolonged effects on preantral follicle development. Preantral granulosa cell-oocyte complexes from 14-day-old mice were cultured under control, chelated (DTPA), or rescue (DTPA + ZnSO4) conditions for up to 10 days. Preantral follicles cultured in DTPA alone showed impaired growth, disrupted nucleolar morphology, and impaired meiotic progression. The granulosa cells in DTPA-treated follicles underwent apoptosis at a higher rate than controls, had fewer physical connections to the oocyte, and reduced activation of pSMAD2 signaling. Moreover, Lhcgr and Ar transcripts were higher in cumulus cells, and Figla was lower in oocytes from DTPA-treated follicles. These data support a role for transition metals in general, and zinc in particular, in proper development of preantral ovarian follicles. The loss of somatic support cells explains some or all of the growth and developmental deficits seen in the DTPA-treated oocytes. DTPA preferentially binds zinc. Therefore, these results support growing evidence that a proper supply of transition metals, including zinc, is essential for optimal ovarian function. Lay summary: The roles the mineral zinc plays in the ovary are not yet clear. The present study used follicles from mouse ovaries that were grown in the lab for up to 10 days. Follicles are round structures that contain a large egg cell at the center, surrounded by smaller cells called granulosa cells. Follicles were either grown with adequate zinc or insufficient zinc levels. The findings show that follicles require sufficient zinc to form connections between the egg and granulosa cells, which are essential for growth of both the egg and the granulosa cells. When there is insufficient zinc, loss of these connections leads to more granulosa cells dying and smaller follicles. These results show that zinc is important for growth of ovarian follicles, which could be important for treating infertility by supplying adequate levels of zinc in the diet.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.